An unresolved clinical case sparks off the first scientific involvement: a bronchoalveolar lavage fluid (BAL) sample was sent from Wuhan Central Hospital to Vision Medicals (广州微远基因科技) in Guangzhou, a private company specializing in metagenomic massive parallel sequencing analysis. According to the GenBank record, the sample was obtained 23 December, whereas sets the date to 24 December 2019.See p. 4 Table 1 in
